ReviewClinical and experimental hepatology2025

Potential pharmacotherapy pathways in metabolic dysfunction-associated steatotic liver disease.

Paweł Rajewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.